MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Consolidator ... Mass Market Scale-up, Global Reach, Public Capital
*Consolidators: Biotechnology
*Consolidators: Biotechnology_BioManufacturing, Biologics Production
Lonza Group (OTCPK:LZAGF) (LONN SW)*
Organization & Developments: Lonza
Parents
Lonza Group (OTCPK:LZAGF) (LONN SW)*
Children
*Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries.
*Its products and services span its customers’ needs from research to final product manufacture.
*Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important
*Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing.
*Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and per
*Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotech
*Lonza Walkersville (FITCI)
*One of the world's leading suppliers to the pharmaceutical, healthcare and life science industries.
2018: Lonza to unveil cell/gene therapy manufacturing facility in Pearland
2022: Lonza: Positive News From Biogen_ seekingalpha.com
2024: Lonza: Acceleration In Mid-Term Sales Growth
Jumps
*Key People: Lonza
Finance & Acquisitions: Lonza